002317 Stock Overview
Guangdong Zhongsheng Pharmaceutical Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥13.04 |
| 52 Week High | CN¥20.10 |
| 52 Week Low | CN¥10.22 |
| Beta | 0.74 |
| 11 Month Change | -3.55% |
| 3 Month Change | 19.85% |
| 1 Year Change | -33.91% |
| 33 Year Change | 6.97% |
| 5 Year Change | 32.39% |
| Change since IPO | 0.69% |
Recent News & Updates
Recent updates
Shareholder Returns
| 002317 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -0.5% | -1.5% | -2.1% |
| 1Y | -33.9% | -9.4% | 2.8% |
Return vs Industry: 002317 underperformed the CN Pharmaceuticals industry which returned -9.4% over the past year.
Return vs Market: 002317 underperformed the CN Market which returned 2.8% over the past year.
Price Volatility
| 002317 volatility | |
|---|---|
| 002317 Average Weekly Movement | 7.0% |
| Pharmaceuticals Industry Average Movement | 7.3% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 002317 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002317's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 1,732 | Yong Hong Chen | www.zspcl.com |
Guangdong Zhongsheng Pharmaceutical Co., Ltd. engages in research, development, production, and sale of pharmaceuticals in China. The company offers Chinese and chemical medicines, raw materials, and intermediates. It is also involved in the research and development of products in the fields of ophthalmology, cardiovascular, cerebrovascular, respiratory, digestive, diabetes, tumor, and senile degenerative diseases.
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Fundamentals Summary
| 002317 fundamental statistics | |
|---|---|
| Market cap | CN¥11.03b |
| Earnings (TTM) | CN¥132.58m |
| Revenue (TTM) | CN¥2.45b |
83.2x
P/E Ratio4.5x
P/S RatioIs 002317 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002317 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.45b |
| Cost of Revenue | CN¥1.10b |
| Gross Profit | CN¥1.35b |
| Other Expenses | CN¥1.22b |
| Earnings | CN¥132.58m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.16 |
| Gross Margin | 55.11% |
| Net Profit Margin | 5.42% |
| Debt/Equity Ratio | 0% |
How did 002317 perform over the long term?
See historical performance and comparison